Clinical Trial Update: Study to Compare the Efficacy and Safety of F-627 and GRAN® [Phase 3]

View source ↗

Summary

Phase 3 trial comparing F-627 with GRAN® in breast cancer; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neutropenia

Drugs mentioned

• F-627
• GRAN®

Snippet

Sponsor: EVIVE Biotechnology | Conditions: Breast Cancer, Neutropenia | Phase 3 | Status: COMPLETED | Results posted: 2025-04-20